Anavex Life Sciences Corp.AVXLNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank43
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Percentile
P43
Within normal range
vs 3Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-26.72%
2024-10.89%
2023-14.63%
202220.23%
2021-42.73%
2020-14.90%
2019-47.25%
2018-39.54%
20172.38%
2016-118.52%